E. Nudo

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

Á. Cruz, L. Brogelli, A. Papi, 2021, Asthma Research and Practice.

Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment

G. Nicolini, E. Nudo, Sara Panigone, 2020, BMJ Open Respiratory Research.

Exploring quality of life and satisfaction with treatment in asthmatic patients receiving dry powder inhalers: a multinational survey

M. Contoli, F. Braido, D. Guastalla, 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study

C. Criée, C. Gessner, F. Trinkmann, 2022, International journal of chronic obstructive pulmonary disease.

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study

C. Criée, C. Gessner, F. Trinkmann, 2022 .

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

W. Henley, N. Roche, H. Kerstjens, 2022, International journal of chronic obstructive pulmonary disease.

Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS

V. Carter, D. Price, J. Cançado, 2024, Pragmatic and observational research.